Clinical Trials Update: Aug. 10, 2006

Schizophrenia and Schizoaffective Disorders Migraine and Cluster Headaches Fibromyalgia

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Schizophrenia and Schizoaffective Disorders

This study is a trial of an outpatient, non-invasive investigational treatment called repetitive transcranial magnetic stimulation (rTMS). It applies a magnetic field to the brain for a brief period of time, involving 45-minute daily sessions each weekday for a series of weeks. Candidates must be 18-55 with primary diagnosis of schizophrenia or schizoaffective disorder, have stable symptoms, and no change in antipsychotic medication for the past four weeks or other psychotropic drugs for two weeks. Volunteers cannot have a neurological disorder, history of seizure or stroke, or be using benzodiazepines of greater than 3 mg.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat135.html.

-----

Migraine and Cluster Headaches

This study will evaluate the impact of percutaneous closure of a patent foramen ovale (a hole in the heart), using the Amplatzer PFO Occluder, on the incidence of migraine headaches. Candidates with migraines who have a PFO and show a refractoriness to medical treatment may be eligible. Volunteers will not qualify if they have a clinical history of stroke or transient ischemic attack, or are pregnant or desire to become pregnant within the next year.

Research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Fibromyalgia

Volunteers ages 18-70 are needed for a research study evaluating an investigational medication for fibromyalgia. If you qualify, you will receive all study-related examinations, lab work and study medication at no cost and may receive compensation for travel expenses.

The research site is in Columbus, Ohio.

More information

Please see http://www.centerwatch.com/patient/studies/cat218.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News